Coherus Biosciences | 销售



金融业
股票价格
USD
资产
USD 516.52M
现金及等价物
USD 103.35M
销售成本
USD 2.65M
流动资产
USD 460.96M
流动负债
USD 372.3M
债务
USD 294.93M
股息收益率
0
EBIT
USD -45.44M
EBITDA
USD -44.34M
员工
306
EPS每股收益
USD -0.35
股本和储备
USD 87.77M
销售毛利
USD 4.95M
债务利息支出
USD 2.15M
贷款资金
USD 294.85M
市值
USD 188.2M
净收入
USD -56.57M
营业费用
USD 53.03M
营业利润
USD -45.44M
普通股股本
USD 12K
税前利润
USD -47.4M
销售收入
USD 7.6M
销售和管理费用
USD 26.03M
股票
USD 2.05M
贸易债权人
USD 24.89M
应收帐款人
USD 62.44M


销售 更改 日
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Akebia Therapeutics USD 57.34M 10.84M 2025-03
ALKERMES USD 384.5M 9.7M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.67M 23.07M 2025-09
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.97B 130M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 7.6M 46.54M 2025-03
Eli Lilly USD 19.3B 1.7B 2025-12
Fujifilm JPY 857.35B 34.47B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
Merck USD 16.4B 880M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12
Zoetis USD 2.4B 0 2025-12


Coherus Biosciences 销售 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.